-
公开(公告)号：US20170339058A1
公开(公告)日：2017-11-23
申请号：US15160043
申请日：2016-05-20
Applicant: Macau University of Science and Technology
Inventor： Qinglin Zhao , Zhijie Ma
IPC: H04L12/801 , H04L12/911 , H04L12/26
CPC classification number: H04L47/10 , H04L43/0882 , H04L47/783 , H04W28/0205 , H04W74/0816
Abstract: A method for optimizing throughput of a network with stations adapted to transmit data to an access point includes the step of determining a respective required throughput for each station based on: respective time periods required for decreasing a count of a respective back-off counter associated with each of the stations, a transmission packet length of the respective station, and a probability of successful transmission for of the respective station. The respective required throughput so determined is a function of a respective transmission attempt rate for the station. The method further includes the step of determining the respective transmission attempt rate for each station for maximizing a sum of the respective required throughput such that a respective fixed throughput is provided for inelastic data flow in the network, a respective proportional throughput ratio is provided for elastic data flow in the network, and the throughput of the network is maximized.
-
公开(公告)号：US20170312266A1
公开(公告)日：2017-11-02
申请号：US15142373
申请日：2016-04-29
Applicant: Macau University of Science and Technology
Inventor： Zhi-Hong Jiang , Jing-Rong Wang , Cheng-Yu Chen , Guo-Yuan Zhu
IPC: A61K31/4745 , A61K36/24
CPC classification number: A61K31/4745 , A61K36/24
Abstract: A method of isolating at least one phenanthroindolizidine alkaloid, in particular with HIF-1 inhibitory activity, from Tylophora atrofolliculata is used to isolate and obtain for example about 22 phenanthroindolizidine alkaloids, including at least 11 new phenanthroindolizidine alkaloids which have not been previously isolated. Experimental tests confirmed an exceptional HIF-1 inhibitory activity of the phenanthroindolizidine alkaloids isolated. A pharmaceutical composition includes at least one phenanthroindolizidine alkaloid and at least one pharmaceutical tolerable excipient. A method of treating a subject suffering from cancer includes administering at least one phenanthroindolizidine alkaloid isolated from Tylophora atrofolliculata. A method of treating a subject suffering from cancer includes administering at least one phenanthroindolizidine alkaloid to the subject.
-
公开(公告)号：US09800367B1
公开(公告)日：2017-10-24
申请号：US15432898
申请日：2017-02-14
Applicant: Macau University of Science and Technology
Inventor： Hong-Ning Dai , Xuran Li , Qiu Wang , Athanasios V. Vasilakos
CPC classification number: H04K3/28 , H04K3/41 , H04K3/42 , H04K3/43 , H04K3/46 , H04K3/825 , H04K2203/34 , H04W4/021 , H04W12/02 , H04W16/00 , H04W48/04
Abstract: A method improves an anti-eavesdropping (AE)-shelter that emits interference signals that protect communication between legitimate transmitters and legitimate receivers in the AE-shelter. The method includes determining a circular boundary for the AE-shelter; improving the AE-shelter by uniformly placing a number of jammers at the boundary; tuning emitting power of the jammers; and improving a coverage area of the interference signals.
-
公开(公告)号：US09782400B2
公开(公告)日：2017-10-10
申请号：US14956620
申请日：2015-12-02
Applicant: Macau University of Science and Technology
Inventor： Xiao Jun Yao , Lai Han Leung , Lian Xiang Luo , Liang Liu
IPC: A01N43/42 , A61K31/444 , A61K31/4745
CPC classification number: A61K31/4745
Abstract: A compound suitable for treating cancer, in particular NSCLC, inhibits activity of oncogenic ROS1 kinase and ALK kinase. The compound has certain structural components such as a quinoline moiety in the backbone and at least one phenyl-containing moiety in a side chain with a hydrophobic substituent attached to the backbone via an up to 6-membered linking group as well as a further hydrophobic moiety. The presence of the structural components allows for an advantageous interaction with the ROS1 kinase domain and, further, with the ALK kinase domain. Hence, said compound represents a highly promising opportunity for patients bearing ROS1- or ALK-dependent cancer. A composition, in particular a pharmaceutical composition, includes the compound. A method for targeting cancer cells harboring an abnormality in ROS1 gene or ALK gene includes contacting a cell with the compound.
-
公开(公告)号：US09755661B1
公开(公告)日：2017-09-05
申请号：US15238033
申请日：2016-08-16
Applicant: Macau University of Science and Technology
Inventor： Zhanchuan Cai , Ting Lan
CPC classification number: H03M7/3082 , G09G5/02 , G09G5/24 , G10L19/018
Abstract: A method for coding data includes: representing a first data in digital form as digital information; transforming the digital information into a first Gaussian integer; determining a relationship between the first Gaussian integer and a second Gaussian integer; and deriving, based on the determined relationship, a key for converting between the first Gaussian integer and the second Gaussian integer so as to associate the first data with a second data represented by the second Gaussian integer. The present invention also provides a system and a non-transient computer readable medium for implementing the method.
-
Patent Agency Ranking
公开(公告)号：US09748853B1
公开(公告)日：2017-08-29
申请号：US15339943
申请日：2016-11-01
Applicant: Macau University of Science and Technology
Inventor： Xiaodong Li
CPC classification number: H02M3/33546 , H02J7/0052 , H02M1/14 , H02M3/33576 , H05B33/0815
Abstract: One example embodiment is a method executed by a microcontroller with a Pulse Width Modulation (PWM) circuit to control a semi-dual-active-bridge (SDAB) converter that includes a first side bridge circuit, a second side bridge circuit and a transformer. The microcontroller determines a current operation mode and a target operation mode of the SDAB converter. The microcontroller determines an optimal ratio and calculates changes of each gating signal that are applied to the first side bridge circuit and the second side bridge circuit respectively.
-
公开(公告)号：US20170169563A1
公开(公告)日：2017-06-15
申请号：US14965918
申请日：2015-12-11
Applicant: Macau University of Science and Technology
Inventor： Yong LIANG , Liang-Yong XIA , Xu-Xin LIN , Xiao-Ying LIU , Kuok-Fan CHAN
CPC classification number: A61B5/055 , A61B5/0044 , A61B5/0263 , G01R33/5608 , G01R33/5611 , G01R33/56308 , G01R33/56366 , H04N19/59 , H04N19/85
Abstract: A method for determining a background component and a dynamic component of an image frame from an under-sampled data sequence obtained in a dynamic MRI application is provided. The two components are determined by optimizing a low-rank component and a sparse component of the image frame in a sense of minimizing a weighted sum of terms. The terms include a Schattenp=1/2 (S1/2-norm) of the low-rank component, an L1/2-norm of the sparse component additionally sparsified by a sparsifying transform, and an L2-norm of a difference between the sensed data sequence and a reconstructed data sequence. The reconstructed one is obtained by sub-sampling the image frame according to an encoding or acquiring operation. The background and dynamic components are the low-rank and sparse components, respectively. Experimental results demonstrate that the method outperforms an existing technique that minimizes a nuclear-norm of the low-rank component and an L1-norm of the sparse component.
-
公开(公告)号：US20170083028A1
公开(公告)日：2017-03-23
申请号：US14919706
申请日：2015-10-21
Applicant: Macau University of Science and Technology
CPC classification number: F04B49/065 , F04B23/04 , F04B2205/09 , F04B2207/041 , G06Q10/0631 , Y02P80/10 , Y02P90/86
Abstract: For sustainable development, a refinery is required to save energy as much as possible so as to reduce the emission of greenhouse gas. In crude oil operations, oil transportation from storage tanks to charging tanks via a pipeline consumes a large portion of energy. It is vitally important to minimize energy consumption for this process. Since the oil flow resistance is proportional to the square of oil flow rate, the relation between energy efficiency and flow rate is nonlinear, which makes the problem complicated. The present invention addresses this important issue by formulating a linear programming model for the considered problem such that it can be efficiently solved. A real-world industrial case study is used to demonstrate the applications and significance of the proposed method.
-
169.发明申请公开(公告)号：US20170083000A1
公开(公告)日：2017-03-23
申请号：US14918570
申请日：2015-10-21
Applicant: Macau University of Science and Technology
Inventor： Naiqi Wu , Zicheng Liu
IPC: G05B19/402 , B25J9/00 , B25J9/16 , B25J11/00
CPC classification number: G05B19/402 , B25J9/1682 , G05B19/41865 , G05B2219/32265 , G05B2219/32373 , G05B2219/32376 , G05B2219/40238 , G05B2219/45031 , H01L21/67276 , Y10S901/02 , Y10S901/41
Abstract: It is very difficult to schedule a single-arm cluster tool with wafer revisiting such that wafer residency time constraints are satisfied. The present invention conducts a study on this challenging problem for a single-arm cluster tool with atomic layer deposition (ALD) process. With a so called p-backward strategy being applied, a Petri net model is developed to describe the dynamic behavior of the system. Based on the model, existence of a feasible schedule is analyzed, schedulability conditions are derived, and scheduling algorithms are presented if there is a schedule. A schedule is obtained by simply setting the robot waiting time if schedulable and it is very computationally efficient. The obtained schedule is shown to be optimal. Illustrative examples are given to demonstrate the proposed approach.
-
公开(公告)号：US20170079972A1
公开(公告)日：2017-03-23
申请号：US14927825
申请日：2015-10-30
Applicant: Macau University of Science and Technology
Inventor： Xiao Jun Yao , Lai Han Leung , Lian Xiang Luo , Liang Liu
IPC: A61K31/4743
CPC classification number: A61K31/4743
Abstract: The administration of a compound advantageously efficacious as ROS1 inhibitor and its effect on subjects with cancer includes administering a compound having certain structural components such as a quinoline moiety in the backbone and at least one tertiary amine containing moiety in a side chain as well as heteroatoms, in particular oxygen atoms, present in the backbone and the side chain for treating a subject suffering from a disease such as cancer. The presence of such structural components allows for an advantageous interaction with the ROS1 kinase domain, in particular with the hinge region. The administered compounds represent a highly promising opportunity in particular for patients bearing ROS1-dependent cancer. A method for targeting tumor cells harboring an abnormality in ROS1 gene includes contacting a cell with compounds of the present invention as well as pharmaceutical compositions comprising such compounds.
-
-
-
-
-
-
-
-
-
Search Results
245
records
(took 0.031 seconds)
